Authors: SCHMASSMANNSUHIJAR D BULLINGHAM R GASSER R SCHMUTZ J HAEFELI WE

Citation: D. Schmassmannsuhijar et al., RHABDOMYOLYSIS DUE TO INTERACTION OF SIMVASTATIN WITH MIBEFRADIL, Lancet, 351(9120), 1998, pp. 1929-1930

Authors: BULLINGHAM R MONROE S NICHOLLS A HALE M

Citation: R. Bullingham et al., PHARMACOKINETICS AND BIOAVAILABILITY OF MYCOPHENOLATE MOFETIL IN HEALTHY-SUBJECTS AFTER SINGLE-DOSE ORAL AND INTRAVENOUS ADMINISTRATION, Journal of clinical pharmacology, 36(4), 1996, pp. 315-324

Authors: PARKER G BULLINGHAM R KAMM B HALE M

Citation: G. Parker et al., PHARMACOKINETICS OF ORAL MYCOPHENOLATE MOFETIL IN VOLUNTEER SUBJECTS WITH VARYING DEGREES OF HEPATIC OXIDATIVE IMPAIRMENT, Journal of clinical pharmacology, 36(4), 1996, pp. 332-344

Authors: SHAH J BULLINGHAM R RICE P TSINA I SWAN S HALSTENSON C

Citation: J. Shah et al., PHARMACOKINETICS OF ORAL MYCOPHENOLATE MOFETIL (MMF) AND METABOLITES IN RENALLY IMPAIRED PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 149-149

Authors: LUCKER P BULLINGHAM R HOOFTMAN L LLOYD J MROSZCZAK E

Citation: P. Lucker et al., TOLERABILITY, CENTRAL EFFECTS AND PHARMACOKINETICS OF INTRAVENOUS KETOROLAC TROMETHAMINE IN VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 32(8), 1994, pp. 409-414

Authors: SHAH J BULLINGHAM R JONKMAN J CURD J TAYLOR R FRATIS A

Citation: J. Shah et al., PK-PD INTERACTION OF KETOROLAC AND FUROSEMIDE IN HEALTHY-VOLUNTEERS IN A NORMOVOLEMIC STATE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 198-198